MedPath

New Health Devices to Improve Adherence to Physical Activity in Overweight Inactive Adults

Not Applicable
Completed
Conditions
Obesity
Cardiovascular Diseases
Interventions
Device: Pai APP
Device: FitBit APP
Registration Number
NCT02774655
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The purpose of this study is to test in overweight and inactive adults whether the new PAI eHealh APP leads to better adherence to a physical activity regimen than the wearable step counter App from the market leader FitBit, and to evaluate if improved adherence will be reflected in a better cardiovascular profile in this group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Body mass index > 25
  • self reported exercise one time or less per week
Exclusion Criteria
  • inability to use a SmartPhone
  • illness or disabilities that preclude or hinder completion of the study
  • cancer that makes participation impossible or exercise contraindicated (considered individually, in consultation with physician)
  • test results indicating that study participation is unsafe
  • participation in other studies conflicting with participation in this study
  • symptomatic valvular, hypertrophic cardiomyopathy, unstable angina, primary pulmonary hypertension, uncontrolled hypertension, heart failure or sever arrhythmia
  • diagnosed dementia
  • chronic communicable infectious diseases
  • Bariatric surgery
  • Medication for thyroid disease, diabetes, blood pressure or lipid lowering medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PAI APPPai APPpersonal activity index application
FitBit APPFitBit APP-
Primary Outcome Measures
NameTimeMethod
The proportion of the participants obtaining 80 % or more of the prescribed physical activity for one year1 year

Prescribed 100 PAI weekly (PAI app group), or 10 000 steps daily (step counter app)

Secondary Outcome Measures
NameTimeMethod
Cardiorespiratory fitness16 weeks

Peak oxygen uptake assessed by Jaeger oxycon pro; Erich Jaeger GmbH, Hoechberg, Germany

Resting blood pressure1 year

Left upper arm, right upper arm, orthostatic hypotension

Resting heart rate1 year
Body mass index1 year

Height, weight

Waist line1 year

in centimeters

Body composition1 year

body composition measured by bioelectrical impedance (InBody 720, BIOSPACE, Seoul, Korea)

Activity questionnaire1 year

HUNT-1 questionnaire 2 "exercise"

glucose concentration in blood1 year
glycosylated haemoglobin (HbA1c) concentration in blood1 year
c-peptide concentration in blood1 year
concentration of triglycerides in blood serum1 year
concentration of total cholesterol in blood1 year
concentration of low density lipid (LDL) cholesterol in blood1 year
concentration of high density lipid (HDL) cholesterol in blood1 year

Trial Locations

Locations (1)

Institutt for sirkulasjon og bildediagnostikk

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath